Ftse Mib
38.421,05
0,45%
DAX
22.287,56
-0,24%
S&P 500
6.013,13
-1,71%
NASDAQ
19.524,01
-2,20%
Bitcoin
95.431,64
-0,87%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aquestive Therapeutics Inc (AQST) Aquestive Therapeutics Inc (AQST) Notizie

Aquestive Therapeutics Inc

AQST
3,04
-0,02 (-0,65%)
22 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/2/202513:00GLOBEAquestive Therapeutics to Report Fourth Quarter 2024..
15/2/202500:12EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
12/2/202513:22EDGAR2Form 8-K - Current report
12/2/202513:00GLOBEAquestive Therapeutics to Present New Findings on Anaphylm™..
04/2/202513:00GLOBEAquestive Therapeutics to Participate in Oppenheimer 35th..
24/1/202522:51EDGAR2Form S-8 - Securities to be offered to employees in employee..
13/1/202513:07EDGAR2Form 8-K - Current report
13/1/202513:00GLOBEAquestive Therapeutics Provides Business Update and Outlines..
19/12/202414:02EDGAR2Form 8-K - Current report
19/12/202414:00GLOBEAquestive Therapeutics Receives U.S. FDA Orphan Drug..
02/12/202414:08EDGAR2Form 8-K - Current report
02/12/202414:00GLOBEAquestive Therapeutics Announces Positive FDA Feedback and..
27/11/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202421:47EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202414:00GLOBEAquestive Therapeutics to Participate in Two Upcoming..
08/11/202423:31EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
07/11/202422:01EDGAR2Form 8-K - Current report
06/11/202422:01EDGAR2Form 8-K - Current report
04/11/202422:40EDGAR2Form 8-K - Current report
04/11/202422:36GLOBEAquestive Therapeutics Reports Third Quarter 2024 Financial..
25/10/202414:05EDGAR2Form 8-K - Current report
25/10/202414:00GLOBEAquestive Therapeutics to Present Subsequent Analysis of..
24/10/202414:06EDGAR2Form 8-K - Current report
24/10/202414:00GLOBEAquestive Therapeutics Announces Positive Topline Results..
21/10/202414:00GLOBEAquestive Therapeutics to Report Third Quarter 2024..
16/10/202423:16EDGAR2Form 8-K - Current report
02/10/202420:16EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
27/9/202414:46EDGAR2Form 8-K - Current report
27/9/202414:30GLOBEAquestive Therapeutics Spotlights its Innovative Epinephrine..
09/9/202414:56EDGAR2Form 8-K - Current report
09/9/202414:15GLOBEAquestive Therapeutics to Hold Virtual Investor Day to..
22/8/202414:00GLOBEAquestive Therapeutics to Participate in Two Upcoming..
14/8/202414:08EDGAR2Form 8-K - Current report
14/8/202414:00GLOBEAquestive Therapeutics Comments on Recent FDA Approval of..
12/8/202420:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202422:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202422:24EDGAR2Form 8-K - Current report
06/8/202422:22GLOBEAquestive Therapeutics Reports Second Quarter 2024 Financial..
25/7/202414:16EDGAR2Form 8-K - Current report
25/7/202414:00GLOBEAquestive Therapeutics Reports Positive Topline Data for..
23/7/202414:00GLOBEAquestive Therapeutics to Report Second Quarter 2024..
27/6/202414:00GLOBEAquestive Therapeutics to Participate in Leerink Partners..
25/6/202414:00GLOBEAquestive Therapeutics Reports Positive Topline Data from..
18/6/202414:00GLOBEAquestive Therapeutics to Join the Russell 3000® and Russell..
11/6/202418:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202418:35EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/6/202414:13EDGAR2Form 8-K - Current report
06/6/202422:05EDGAR2Form 8-K - Current report
03/6/202414:00GLOBEAquestive Therapeutics Announces Executive Appointments and..
28/5/202414:00GLOBEAquestive Therapeutics to Present Anaphylm™ (epinephrine)..
Apertura: 3,12 Min: 3,01 Max: 3,15
Chiusura: 3,06

La tua Cronologia

NASDAQ
AQST
Aquestive Therapeutics
BIT
UB5LXE
Unicredit Bank
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci